129 related articles for article (PubMed ID: 24182219)
21. Prostate cancer: Determining optimal therapy of early-stage disease remains complicated.
Canes D
Nat Rev Urol; 2016 Dec; 13(12):703-704. PubMed ID: 27824351
[No Abstract] [Full Text] [Related]
22. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
[TBL] [Abstract][Full Text] [Related]
23. Summaries for patients. Screening smarter, not harder, for prostate cancer.
Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
[No Abstract] [Full Text] [Related]
24. Re: Cost-Effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data.
Taneja SS
J Urol; 2015 Jul; 194(1):113-4. PubMed ID: 26088223
[No Abstract] [Full Text] [Related]
25. Re: Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
Noordzij MA; Blanker MH
J Natl Cancer Inst; 2015 Jun; 107(6):djv110. PubMed ID: 25888716
[No Abstract] [Full Text] [Related]
26. Prostate cancer.
Mazhar D; Waxman J
Postgrad Med J; 2002 Oct; 78(924):590-5. PubMed ID: 12415080
[TBL] [Abstract][Full Text] [Related]
27. Mass screening of prostate cancer in Vietnam: current status and our opinions.
Vu Le C; Dao OQ; Khac Tran LN
Urol Oncol; 2010; 28(6):673-6. PubMed ID: 21062650
[TBL] [Abstract][Full Text] [Related]
28. [Early detection or screening in the prevention of prostate cancer?].
Brenes Bermúdez FJ; Alcántara Montero A
Semergen; 2017 Mar; 43(2):100-108. PubMed ID: 26960257
[TBL] [Abstract][Full Text] [Related]
29. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
Zürcher S
Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
[No Abstract] [Full Text] [Related]
30. The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States.
Guo F; He D
Ann Intern Med; 2015 Oct; 163(8):650-1. PubMed ID: 26502132
[No Abstract] [Full Text] [Related]
31. Response.
Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2015 Jun; 107(6):djv111. PubMed ID: 25888717
[No Abstract] [Full Text] [Related]
32. Screening for prostate cancer starting at age 50-54 years.
Joob B; Wiwanitkit V
J Cancer Res Ther; 2019 Mar; 15(Supplement):S177. PubMed ID: 30900644
[No Abstract] [Full Text] [Related]
33. Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
Prasad V
Med Hypotheses; 2016 Aug; 93():71-3. PubMed ID: 27372859
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities.
Tian JY; Guo FJ; Zheng GY; Ahmad A
Carcinogenesis; 2018 Mar; 39(3):307-317. PubMed ID: 29216344
[TBL] [Abstract][Full Text] [Related]
35. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.
Jia Y; Zhu LY; Xian YX; Sun XQ; Gao JG; Zhang XH; Hou SC; Zhang CC; Liu ZX
World J Surg Oncol; 2017 Aug; 15(1):165. PubMed ID: 28851376
[TBL] [Abstract][Full Text] [Related]
36. [Current aspects of prostate cancer screening].
Jalón Monzón A; Escaf Barmadah S; Viña Alonso LM; Jalón Monzón M
Semergen; 2017; 43(5):387-393. PubMed ID: 27562331
[TBL] [Abstract][Full Text] [Related]
37. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
38. General practitioner (GP)'s view on screening for prostate cancer in the Netherlands: the impact of a randomized trial.
Schröder FH
BJU Int; 2013 Jul; 112(1):4-5. PubMed ID: 23759003
[No Abstract] [Full Text] [Related]
39. Prostate cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines.
Richie JP; Murphy GP; Walther P
Oncology (Williston Park); 1997 Jun; 11(6):907-12. PubMed ID: 9189945
[No Abstract] [Full Text] [Related]
40. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
Mian BM
Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
